Vet Pathol Download to Citation Manager
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Starost, M. F.
Right arrow Articles by Conti, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Starost, M. F.
Right arrow Articles by Conti, C. J.
Vet Pathol 39:390-392 (2002)
© 2002 American College of Veterinary Pathologists


BRIEF COMMUNICATIONS AND CASE REPORTS

A Variant of Pulmonary Alveolar Microlithiasis in nackt Mice

M. F. Starost, F. Benavides and C. J. Conti

Abstract

Four adult mutant nackt mice, which demonstrate alopecia and CD4+ T-cell deficiency, and two outbred SENCAR mice (sentinels) were presented for routine health surveillance. Lesions were not observed at necropsy. Microscopically, all four nackt mice demonstrated multiple concretions that were 30–100 µm in diameter, irregularly rounded to oval, nonbirefringent, and amphophilic to basophilic. Many of the concretions appeared attached to or within the alveolar walls of all lung lobes. Approximately half of the concretions had irregular fracture lines. All concretions were periodic acid–Schiff positive, and Von Kassa staining revealed diffuse calcification. None of the concretions were associated with inflammatory cell infiltrates, and metaplastic ossification was not evident. A diagnosis of pulmonary alveolar microlithiasis, a rare disease in both humans and animals, was made based on the size and location of the concretions and the lack of an inflammatory response. This is the first report of a laboratory mouse demonstrating pulmonary alveolar microlithiasis.


Key words: Lung; mutant mice; nackt mice; pulmonary alveolar microlithiasis.

Pulmonary alveolar microlithiasis is a rare condition in humans and animals with an unknown cause. The disease is characterized by the formation of calcium phosphate microliths (calcospherites) within the alveoli of the lungs without an associated inflammatory response. This disease was first described in humans by Harbitz11 in 1918 as extensive calcification of the lungs. In 1933, Puhr22 gave the disease the name alveolar microlithiasis. Since then, slightly more than 200 individual and small group case reports have been documented in the human literature.17,19,21,24,25 The veterinary medical literature has even fewer documented reports of alveolar microlithiasis found only in four dogs,5,8,15 a cat,6 a binturong,7 an orangutan,13 and a breeding colony of Afghan pikas.16 The pikas have the potential for being an animal model for alveolar microlithiasis because of its familial occurrence in this species. Our report documents a variant of pulmonary alveolar microlithiasis, presumably the early stages of the disease, in nackt mice.

We recently reported the nackt mouse mutation that affects skin and CD4+ T-cell development.3 Nackt is an autosomal recessive mutation with complete penetrance that was originally mapped to mouse chromosome 13, at a location 37 centiMorgans distal from the centromere. Affected animals show sparse, rough pelage from the first hair coat followed by regrowth and renewed hair loss during the subsequent hair cycle. The neck and back of adult mutant mice remain alopecic throughout life, and histologically the epidermis is hyperplastic with acanthosis and epidermal and follicular orthokeratosis. The most striking immunologic finding is a marked decrease in the proportion of CD4+ T cells in the thymus and peripheral lymphoid tissues. The nackt mutation represents a 118-base pair deletion of the cathepsin L gene, which is required for degradation of the invariant chain, a critical chaperone for major histocompatibility complex class II molecules.4

Four adult nackt mice (three female and one male) and two adult outbred SENCAR female mice, a strain unrelated to nackt that is sensitive to carcinogens, from the Department of Carcinogenesis at the University of Texas M. D. Anderson Cancer Center were presented for routine health surveillance. Mice were housed in specific pathogen–free rooms in a facility accredited by the American Association for The Accreditation of Laboratory Animal Care. Mice were kept in suspended polycarbonate cages (Lab Products, Maywood, NJ) with autoclaved hardwood bedding (PJ Murphy Forest Products Corp., Montville, NJ). Room environment was controlled at 20–22 C, 60–70% humidity, and 14 hours of light/10 hours of dark. Commercial pelleted rodent food (Harlan Teklad, Madison, WI) and autoclaved reverse osmosis water were available ad libitum. After euthanasia by carbon dioxide, complete necropsies were performed on all the animals, and standard tissues were collected and placed in 10% formalin. All tissues were then processed, paraffin-embedded, stained with hematoxylin and eosin (HE), and evaluated microscopically.

The lungs of all four mutant nackt mice were similarly affected. Within multiple alveolar lumina of each lung lobe, comprising no more than 5% of the total lung field, were amorphous to partially laminated (onion ringed) concretions that appeared to be attached to or within the alveolar wall (Figs. 1, 2). An occasional concretion was seen free within an alveolar or bronchiolar lumen. The concretions ranged in diameter from 30 to 100 µm and were irregularly rounded to oval, nonbirefringent, and amphophilic to basophilic. Approximately half of the concretions had irregular fracture lines. All concretions were periodic acid–Schiff positive, and Von Kassa staining revealed diffuse calcification. None of the concretions were associated with inflammatory cell infiltrates, and metaplastic ossification was not a feature in these animals. The alveolar walls, interstitium, and pulmonary vasculature appeared normal. These concretions were not observed in either of the SENCAR sentinel mice examined. A diagnosis of pulmonary alveolar microlithiasis was made based on the size and location of the concretions and the lack of an inflammatory response.



View larger version (87K):
[in this window]
[in a new window]
 
Fig. 1. Lung; nackt mouse. Multiple microliths of various sizes are attached to or within alveolar walls (arrows). Note the irregular fracture line (arrowhead) and absence of inflammation. HE. Bar = 30 µm.
Fig. 2.) Lung; nackt mouse. Detailed view of a microlith. Note the laminations. HE. Bar = 15 µm.

 
In previous reports of microlithiasis in the human and veterinary literature, microliths were so numerous that the lungs were gritty on palpation, large numbers of alveolar lumina were filled, and in some cases decalcification of the lung was necessary to allow proper processing for microscopic evaluation.5,15,19,20,21 In some of these reports, the diameter of the microliths reached or exceeded 1 mm.15,25 In the mice we examined, the microliths were not discernible on palpation, filled only approximately 5% of alveolar lumina, and did not exceed 100 µm in diameter. However, the size and in some cases the number of the microliths were similar to those reported in Afghan pikas16 and dogs.8

The differential diagnosis of pulmonary alveolar microlithiasis includes pulmonary ossification, pulmonary corpora amylacea, and so-called blue bodies. In pulmonary ossification, the particles of bone are deposited haphazardly throughout the parenchyma, including the interstitium. Ossification was not observed in any of the nackt mice. Osseous metaplasia has been seen in dogs5,15 and Afghan pikas16 with pulmonary alveolar microlithiasis. The ossification was presumed to be the conversion of microliths into bone.5 Pulmonary corpora amylacea are laminated, rounded bodies found in emphysematous and normal lungs of elderly humans. Their eosinophilia in HE-stained sections and their failure to demonstrate calcification aid in the differentiation of corpora amylacea from microliths. In contrast, the microliths in the nackt mice were calcified, as demonstrated with von Kassa stain. Pulmonary blue bodies are intra-alveolar, laminated, basophilic concretions consisting of calcium carbonate in a mucopolysaccharide matrix.14 They usually occur in interstitial pneumonitides that resemble idiopathic desquamative interstitial pneumonia in human beings.14 In a cat reported to have microlithiasis in conjunction with bronchopneumonia, the concretions may have actually been blue bodies because they consisted of calcium carbonate.6 Pulmonary microliths are readily distinguished from blue bodies by their larger size (blue bodies are 15–40 µm and microliths are 250–750 µm) and their different chemical composition (calcium phosphate).19 Pulmonary alveolar microlithiasis also differs from blue bodies by the common absence of inflammation.19 Although many of the concretions observed in the nackt mice were similar in size to blue bodies, some were larger, and the absence of inflammation contributed to these concretions being diagnosed as a variant, or the early formative stage, of microlithiasis. A similar diagnosis was made in a human based on the size of the concretions (<100 µm in diameter) and the absence of laminations and inflammation.1 The microliths in these mice may have eventually enlarged by the addition of calcium phosphate to the external surface, enhancing the visibility of the laminations. Chemical analysis was not performed on the microliths in the nackt mice.

Pulmonary alveolar microlithiasis occurs with both a familial pattern and a sporadic pattern.17,19,25 It affects all ages, and there is no gender predilection.17,19 Possible etiologies include an inherited metabolic abnormality in the lung,19 abnormalities in calcium and phosphorus metabolism,2 abnormalities in the immune system,18 environmental factors,19,21 and anatomic and physiologic abnormalities of the lung.19,25 Although nackt mice are maintained in congenic strains, evaluation of archived tissue and more recent animals presented for routine health surveillance (>20 mice) has failed to demonstrate microlithiasis. Therefore, this disease entity in this group of nackt mice is sporadic and may have been related to an unknown environmental factor, possibly in association with immunosuppression or the lack of functional cathepsin L, a ubiquitous scavenger enzyme believed to be involved in intracellular protein degradation,4 in these mice.

Alveolar microlithiasis has been seen in association with other human medical conditions such as milk alkali syndrome,20 diaphyseal aclasia,23 pectus excavatum,12 and hypertrophic pulmonary osteoarthropathy.10 There have been additional cases of microlithiasis affecting extrapulmonary sites such as the sympathetic ganglia,9 gonads,9 and seminal vesicles2 in association with pulmonary alveolar microlithiasis. Microliths were not observed in any other tissues examined in the nackt mice.

Currently, no known medical treatment for pulmonary alveolar microlithiasis is available, and the disease can progress to the extent of compromising lung capacity and contributing to heart failure.19 Total lung transplantation is the only known cure for advanced disease.17 Although alveolar microlithiasis is sporadic in mice with the nackt mutation, these mice may be a useful model contributing to a better understanding, treatment, and cure of pulmonary alveolar microlithiasis.

References

  1. Abdullah AK, Jarrar G, Ejeckam GC: Idiopathic pulmonary calcinosis: a variant of alveolar microlithiasis. East Afr Med J 71:543-544, 1994[Medline]
  2. Arslan A, Yalin T, Akan H, Belet U: Pulmonary alveolar microlithiasis associated with calcifications in the seminal vesicles. J Belge De Radiologie (Bruxelles) 79:118-119, 1996
  3. Benavides F, Giordano M, Fiette L, Brunialti ALB, Palenzuela NM, Vanzulli S, Baldi P, Schmidt R, Pasqualini CD, Guenet JL: Nackt (nkt), a new hair loss mutation of the mouse with associated CD4 deficiency. Immunogenetics 49:413-419, 1999[CrossRef][Medline]
  4. Benavides F, Venables A, Klug HP, Glasscock E, Rudensky A, Gomez M, Palenzuela NM, Guenet JL, Richie ER, Conti CJ: The CD4 T-deficient mouse mutation nackt (nkt) involves a deletion in the cathepsin L (Ctsl) gene. Immunogenetics 53:233-242, 2001[CrossRef][Medline]
  5. Brix AE, Latimer KS, Moore GE, Roberts RE: Pulmonary alveolar microlithiasis and ossification in a dog. Vet Pathol 31:382-385, 1994[Medline]
  6. Brummer DG, French TW, Cline JM: Microlithiasis associated with chronic bronchopneumonia in a cat. J Am Vet Med Assoc 194:1061-1064, 1989[Medline]
  7. Bush M, James AE, Montali RJ, Stitik FP: Pulmonary alveolar microlithiasis in a binturong (Arctictis binturong): a case report. J Am Vet Radiol Soc 17:157-160, 1976
  8. Caceres MH, Genta RM: Pulmonary microcalcifications associated with Strongyloides stercoralis infection. Chest 94:862-865, 1988[Abstract/Free Full Text]
  9. Coetzee T: Pulmonary alveolar microlithiasis with involvement of the sympathetic nervous system and gonads. Thorax 25:637-642, 1970[Abstract/Free Full Text]
  10. Emri S, Coplu L, Selcuk ZT, Sahin AA, Baris YI: Hypertrophic pulmonary osteo-arthropathy in a patient with pulmonary alveolar microlithiasis. Thorax 46:145-146, 1991[Abstract/Free Full Text]
  11. Harbitz F: Extensive calcification of the lungs as a distinct disease. Arch Intern Med 21:139-146, 1918
  12. Hasan S, Cevat O, Sami C, Tahir Y, Mehmet G, Sadi SG: Pulmonary alveolar microlithiasis with pectus excavatum. Case report. Indian J Med Sci 48:199-200, 1994[Medline]
  13. Kelly DF: Pulmonary alveolar microlithiasis in the orang-utan (Pongo pygmaeus). Acta Zool Pathol Antverp 66:53-57, 1976
  14. Koss MN, Johnson FB, Hochholzer L: Pulmonary blue bodies. Hum Pathol 12:258-266, 1981[Medline]
  15. Liu SK, Suter PF, Ettinger S: Pulmonary alveolar microlithiasis with ruptured chordae tendineae in mitral and tricuspid valves in a dog. J Am Vet Med Assoc 155:1692-1703, 1969[Medline]
  16. Madarame H, Kumagai M, Suzuki J, Watanabe A, Konno S: Pulmonary alveolar microlithiasis in Afghan pika (Ochotona rufescens rufescens). Vet Pathol 26:333-337, 1989[Abstract]
  17. Mariotta S, Guidi L, Papale M, Ricci A, Bisetti A: Pulmonary alveolar microlithiasis: review of Italian cases. Eur J Epidemiol 13:587-590, 1997[CrossRef][Medline]
  18. Meyer HH, Gilbert ES, Kent G: A clinical review of pulmonary microlithiasis. J Am Med Assoc 161:1153-1157, 1956
  19. Moran CA, Hochholzer L, Hasleton PS, Johnson FB, Koss MN: Pulmonary alveolar microlithiasis. A clinicopathologic and chemical analysis of seven cases. Arch Pathol Lab Med 121:607-611, 1997[Medline]
  20. Portnoy LM, Amadeo B, Hennigar GR: Pulmonary alveolar microlithiasis: an unusual case (associated with milk-alkali syndrome). Am J Clin Pathol 41:194-201, 1964
  21. Prakash UB, Barham SS, Rosenow EC, Brown ML, Payne WS: Pulmonary alveolar microlithiasis. A review including ultrastructural and pulmonary function studies. Mayo Clin Proc 58:290-300, 1983[Medline]
  22. Puhr L: Mikrolithiasis alveolaris pulmonum. Virchows Arch Pathol Anat 290:156-160, 1933
  23. Ritchie DA, O'Connor SA, McGivern D: An unusual presentation of pulmonary alveolar microlithiasis and diaphyseal aclasia. Br J Radiol 65:178-181, 1992[Medline]
  24. Schmidt H, Lorder U, Kitz R, Zielen S, Abrens P, Konic R: Pulmonary alveolar microlithiasis in children. Pediatr Radiol 26:33-36, 1996[CrossRef][Medline]
  25. Sosman MC, Dodd GD, Jones WD, Pillmore GU: The familial occurrence of pulmonary alveolar microlithiasis. Am J Roentgenol Radium Ther Nucl Med 77:947-1012, 1957[Medline]
Request reprints from Dr. M. Starost, University of Texas M.D. Anderson Cancer Center, Department of Veterinary Sciences, 650 Cool Water Drive, Bastrop, TX 78602 (USA). E-mail: mstarost{at}mdanderson.org.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
Arterial calcifications and increased expression of vitamin D receptor targets in mice lacking TIF1{alpha}
PNAS, February 19, 2008; 105(7): 2598 - 2603.



Home page
Vet PatholHome page
J. P. Sundberg

Vet. Pathol., March 1, 2003; 40(2): 222 - 222.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Starost, M. F.
Right arrow Articles by Conti, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Starost, M. F.
Right arrow Articles by Conti, C. J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS